- The new IVDR-certified Real-Time PCR assay enables rapid molecular screening of Candida auris , supporting laboratories in strengthening infection prevention and control strategies.
Turin, Italy – August 3, 2026 . ELITechGroup – A Bruker Company, announces the commercial launch of the Candida auris ELITe MGB® Kit, an IVDR-certified Real-Time PCR assay for the rapid molecular screening of Candida auris directly from axillary and groin swabs.
As Candida Auris continues to emerge as a major healthcare-associated fungal pathogen worldwide, early identification of colonized patients has become increasingly important to support infection prevention and control programs. This new assay expands ELITechGroup’s molecular diagnostics portfolio with a standardized solution designed to help laboratories identify colonization rapidly and support timely clinical decision-making.
Validated on the ELITe InGenius® and ELITe BeGenius® platforms, the Candida auris ELITe MGB® Kit provides a fully automated Sample-to-Result workflow, integrating nucleic acid extraction, Real-Time PCR amplification and result interpretation into a single streamlined process.
The launch of the Candida auris ELITe MGB® Kit reinforces ELITechGroup’s commitment to delivering innovative molecular diagnostic solutions that support laboratories address emerging infectious threats through rapid, reliable and standardized testing.
About Us
ELITechGroup is part of Bruker Corporation and contributes to the Bruker Microbiology & Infection Diagnostics (BMID) division, developing cutting-edge technologies to support the evolving needs of clinical laboratories globally.
